Dr. Shoag is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
11100 Euclid Ave
Cleveland, OH 44106Phone+1 216-844-3299
Education & Training
New York Presbyterian Hospital (Columbia and Cornell Campus)Fellowship, Minimally Invasive Urologic Surgery, 2018 - 2020
Weill CornellMS, Clinical and Translational Investigation, 2018 - 2020- New York Presbyterian Hospital (Cornell Campus)Residency, Urology, 2013 - 2018
- Massachusetts Institute of TechnologyHST, 2007 - 2012
Harvard Medical SchoolClass of 2012, MD, Magna cum Laude, Honors- University of PennsylvaniaBa, Biology, Summa cum Laude, phi beta kappa, 2003 - 2007
Certifications & Licensure
OH State Medical License 2020 - 2026
PA State Medical License 2024 - 2024
NY State Medical License 2019 - 2021- American Board of Urology Urology
Publications & Presentations
PubMed
- Outcomes and Cost of Donor Nephrectomy Across Surgical Specialties and Operative Approaches.Jack C Millot, Ilon Weinstein, Camilo Arenas-Gallo, Adithya Balasubramanian, Stephen Rhodes
Urology Practice. 2024-11-01 - 1 citationsReply to Letter to the Editor on "Major Complications and Adverse Events Related to Use of SpaceOAR Hydrogel for Prostate Cancer Radiotherapy".Jack C Millot, Camilo Arenas-Gallo, Jonathan E Shoag
Urology. 2024-10-01 - 1 citationsTransperineal vs Transrectal Prostate Biopsy-The PREVENT Randomized Clinical Trial.Jim C Hu, Melissa Assel, Mohammad E Allaf, Andrew J Vickers, Behfar Ehdaie
JAMA Oncology. 2024-09-19
Journal Articles
- Reconsidering the Trade-Offs of Prostate Cancer ScreeningJonathan E Shoag, Jim C Hu, The New England Journal of Medicine
Authored Content
- Reconsidering the Trade-Offs of Prostate Cancer ScreeningJune 2020
Press Mentions
Active Surveillance in Prostate Cancer Is Growing: What It Is and in Which Patients It Is IndicatedApril 18th, 2023- More Men with Prostate Cancer Are Opting for Active SurveillanceApril 5th, 2023
- More U.S. Prostate Cancer Patients Choosing Active Surveillance over TreatmentApril 5th, 2023
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
